Per favore
selezionare il paese

Attenzione, le pagine di questa sezione sono disponibili solo in lingua inglese.

Selezionando la visualizzazione internazionale, l'utente dichiara di risiedere al di fuori degli Stati Uniti e di voler visualizzare le informazioni sui prodotti internazionali di DiaSorin Molecular. Questo materiale è destinato esclusivamente ai visitatori internazionali (non statunitensi) del sito.

Ai sensi delle Linee Guida del Ministero della Salute del 28/03/2013 in materia di pubblicità sanitaria relativa a dispositivi medici, dispositivi medico-diagnostici in vitro e presidi medico-chirurgici, si informa che le informazioni contenute in questo sito e alle quali si accede sono destinate esclusivamente agli operatori professionali.

NxTAG^® Respiratory Pathogen Panel

Detect 20 respiratory pathogens in a single well, enabling thorough respiratory health analysis

Simplify your syndromic diagnostic testing with pre-plated, lyophilized reagents to facilitate a simple workflow with just one pipetting step, ensuring an easy fit in any lab’s daily routine.

Pannello dei patogeni delle vie respiratorie con tecnologia NxTAG® - Diasorin

Disease state

Respiratory tract infections involve a wide variety of etiologic agents, and present with overlapping signs and symptoms. Prediction of the causative organism based on clinical findings alone is not reliable. The most frequent agents responsible for respiratory infections are respiratory viruses, and then bacteria. Ensuring accurate detection of causitave agents especially in high risk individuals, critically ill patients or to reflexing to determine unknown causes in ongoing sick individuals negative by targeted tests is key for appropriate patient managment and or isolation. Panel testing is also highly valuable in determining respiratory pathogen outbreaks outside winter seasons.

Acute respiratory infection (ARI) is a leading cause of morbidity and mortality worldwide

The value of NxTAG^® Respiratory Pathogen Panel

Empower laboratories with a cost effective, highly scalable syndromic respiratory panel

Clinical impact

Guide timely and appropriate treatment decisions for inpatients and high-risk patients, as well as co-infections and fluctuating etiological agents.

Outstanding economic value

Inexpensive reagents within a closed tube system reduce total workflow costs and minimize contamination.

Flexible format

A 96-well plate with breakaway wells saves valuable laboratory work and storage space and allows the flexibility to easily process 8 to 96 tests.

How the NxTAG^® Respiratory Pathogen Panel Test works

NxTAG^® Respiratory Pathogen Panel is a multiplexed in vitro diagnostic test for the detection and identification of respiratory disease causing viruses and bacterial. Results are produced for 24 extracted DNA samples in less than 3 hours with only a single pipetting step.

Add sample

Add 1-96 extracted samples to the pre-plated, lyophilized test reagents.

Run test

Integrated multiplex PCR and bead hybridization.

Generate results

Read on the NxTAG^®-Enabled MAGPIX^® System.

Indications for NxTAG^® Respiratory Pathogen Panel use

Diagnostic

A qualitative test intended for the simultaneous detection and identification of nucleic acids from multiple respiratory viruses and bacteria extracted from upper respiratory tract specimens

Patients

Hospitalized, Emergency Room or outpatient individuals with clinical signs and symptoms of a respiratory tract infection

Area

High Complexity Hospital, Public Health or Reference Laboratories